Unknown

Dataset Information

0

Proton magnetic resonance spectroscopy detects cerebral metabolic derangement in a mouse model of brain coenzyme a deficiency.


ABSTRACT:

Background

Pantothenate kinase (PANK) is the first and rate-controlling enzymatic step in the only pathway for cellular coenzyme A (CoA) biosynthesis. PANK-associated neurodegeneration (PKAN), formerly known as Hallervorden-Spatz disease, is a rare, life-threatening neurologic disorder that affects the CNS and arises from mutations in the human PANK2 gene. Pantazines, a class of small molecules containing the pantazine moiety, yield promising therapeutic effects in an animal model of brain CoA deficiency. A reliable technique to identify the neurometabolic effects of PANK dysfunction and to monitor therapeutic responses is needed.

Methods

We applied 1H magnetic resonance spectroscopy as a noninvasive technique to evaluate the therapeutic effects of the newly developed Pantazine BBP-671.

Results

1H MRS reliably quantified changes in cerebral metabolites, including glutamate/glutamine, lactate, and N-acetyl aspartate in a neuronal Pank1 and Pank2 double-knockout (SynCre+ Pank1,2 dKO) mouse model of brain CoA deficiency. The neuronal SynCre+ Pank1,2 dKO mice had distinct decreases in Glx/tCr, NAA/tCr, and lactate/tCr ratios compared to the wildtype matched control mice that increased in response to BBP-671 treatment.

Conclusions

BBP-671 treatment completely restored glutamate/glutamine levels in the brains of the mouse model, suggesting that these metabolites are promising clinically translatable biomarkers for future therapeutic trials.

SUBMITTER: Li Y 

PROVIDER: S-EPMC8867880 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Proton magnetic resonance spectroscopy detects cerebral metabolic derangement in a mouse model of brain coenzyme a deficiency.

Li Yanan Y   Steinberg Jeffrey J   Coleman Zane Z   Wang Shubo S   Subramanian Chitra C   Li Yimei Y   Patay Zoltan Z   Akers Walter W   Rock Charles O CO   Jackowski Suzanne S   Bagga Puneet P  

Journal of translational medicine 20220223 1


<h4>Background</h4>Pantothenate kinase (PANK) is the first and rate-controlling enzymatic step in the only pathway for cellular coenzyme A (CoA) biosynthesis. PANK-associated neurodegeneration (PKAN), formerly known as Hallervorden-Spatz disease, is a rare, life-threatening neurologic disorder that affects the CNS and arises from mutations in the human PANK2 gene. Pantazines, a class of small molecules containing the pantazine moiety, yield promising therapeutic effects in an animal model of bra  ...[more]

Similar Datasets

| S-EPMC4174428 | biostudies-literature
| S-EPMC7831222 | biostudies-literature
| S-EPMC4876042 | biostudies-literature
| S-EPMC5951728 | biostudies-literature
| S-EPMC10525730 | biostudies-literature
| S-EPMC11832064 | biostudies-literature
| S-EPMC8776136 | biostudies-literature
| S-EPMC11825355 | biostudies-literature
| S-EPMC5226623 | biostudies-literature
| S-EPMC3482548 | biostudies-literature